Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2686 | 2101 | 46.1 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
412 | 16030 | GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COXSACKIE ADENOVIRUS RECEPTOR | Author keyword | 68 | 84% | 2% | 37 |
2 | GENE TRANSFER REGULAT | Address | 48 | 63% | 2% | 48 |
3 | COXSACKIE AND ADENOVIRUS RECEPTOR | Author keyword | 44 | 88% | 1% | 21 |
4 | HUMAN GENE THER Y | Address | 32 | 21% | 7% | 139 |
5 | VIROL PATHOGENESE VIRALE | Address | 25 | 73% | 1% | 19 |
6 | PROTEIN IX | Author keyword | 24 | 91% | 0% | 10 |
7 | TRANSLAT IMMUNOVIROL PROGRAM | Address | 21 | 85% | 1% | 11 |
8 | ADENOVIRUS VECTOR | Author keyword | 20 | 20% | 4% | 90 |
9 | PENTON BASE | Author keyword | 19 | 74% | 1% | 14 |
10 | HCAR | Author keyword | 17 | 100% | 0% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COXSACKIE ADENOVIRUS RECEPTOR | 68 | 84% | 2% | 37 | Search COXSACKIE+ADENOVIRUS+RECEPTOR | Search COXSACKIE+ADENOVIRUS+RECEPTOR |
2 | COXSACKIE AND ADENOVIRUS RECEPTOR | 44 | 88% | 1% | 21 | Search COXSACKIE+AND+ADENOVIRUS+RECEPTOR | Search COXSACKIE+AND+ADENOVIRUS+RECEPTOR |
3 | PROTEIN IX | 24 | 91% | 0% | 10 | Search PROTEIN+IX | Search PROTEIN+IX |
4 | ADENOVIRUS VECTOR | 20 | 20% | 4% | 90 | Search ADENOVIRUS+VECTOR | Search ADENOVIRUS+VECTOR |
5 | PENTON BASE | 19 | 74% | 1% | 14 | Search PENTON+BASE | Search PENTON+BASE |
6 | HCAR | 17 | 100% | 0% | 8 | Search HCAR | Search HCAR |
7 | COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR | 16 | 60% | 1% | 18 | Search COXSACKIEVIRUS+AND+ADENOVIRUS+RECEPTOR | Search COXSACKIEVIRUS+AND+ADENOVIRUS+RECEPTOR |
8 | HEXON | 13 | 43% | 1% | 23 | Search HEXON | Search HEXON |
9 | TROPISM MODIFICATION | 12 | 86% | 0% | 6 | Search TROPISM+MODIFICATION | Search TROPISM+MODIFICATION |
10 | ADENOVIRUS SEROTYPE 35 VECTOR | 11 | 100% | 0% | 6 | Search ADENOVIRUS+SEROTYPE+35+VECTOR | Search ADENOVIRUS+SEROTYPE+35+VECTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FIBER PROTEIN | 133 | 81% | 4% | 79 |
2 | CAR BINDING | 118 | 95% | 2% | 39 |
3 | PENTON BASE | 108 | 83% | 3% | 60 |
4 | FIBER KNOB | 76 | 70% | 3% | 64 |
5 | SUBGROUP C | 71 | 60% | 4% | 77 |
6 | HI LOOP | 65 | 78% | 2% | 43 |
7 | HEPARAN SULFATE GLYCOSAMINOGLYCANS | 62 | 73% | 2% | 48 |
8 | CELLULAR RECEPTORS | 57 | 71% | 2% | 46 |
9 | COXSACKIEVIRUS | 55 | 47% | 4% | 86 |
10 | BINDING ABLATION | 44 | 88% | 1% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls | 2015 | 2 | 90 | 36% |
Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field | 2014 | 12 | 183 | 50% |
Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting | 2011 | 46 | 161 | 65% |
Adenovirus receptors: implications for targeting of viral vectors | 2012 | 24 | 85 | 76% |
Current advances and future challenges in adenoviral vector biology and targeting | 2007 | 98 | 165 | 79% |
Adenoviruses: update on structure and function | 2009 | 94 | 219 | 58% |
The influence of adenovirus fiber structure and function on vector development for gene therapy | 2005 | 96 | 94 | 93% |
Latest Insights on Adenovirus Structure and Assembly | 2012 | 22 | 136 | 64% |
Adenovirus receptors: implications for tropism, treatment and targeting | 2009 | 56 | 116 | 72% |
Engineering targeted viral vectors for gene therapy | 2007 | 231 | 139 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE TRANSFER REGULAT | 48 | 63% | 2.3% | 48 |
2 | HUMAN GENE THER Y | 32 | 21% | 6.6% | 139 |
3 | VIROL PATHOGENESE VIRALE | 25 | 73% | 0.9% | 19 |
4 | TRANSLAT IMMUNOVIROL PROGRAM | 21 | 85% | 0.5% | 11 |
5 | VIROL GENE THER Y PROGRAM | 9 | 64% | 0.4% | 9 |
6 | STENA 1B | 8 | 75% | 0.3% | 6 |
7 | HEARST FDNMOL BIOL PROGRAM | 4 | 67% | 0.2% | 4 |
8 | TRANSLAT IMMUNOVIROL BIODEFENSE PROGRAM | 4 | 67% | 0.2% | 4 |
9 | TRANSLAT IMMUNOVIROL BIODEF PROGRAM | 4 | 42% | 0.4% | 8 |
10 | BIOTECHNOL THER EUT | 4 | 20% | 0.8% | 17 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000277965 | MOL MED GENE THER Y UNIT//GUTLESS//HELPER DEPENDENT ADENOVIRUS |
2 | 0.0000153066 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS |
3 | 0.0000122016 | BIOL MOL ELADIO VINUELA//PHAGE PHI 29//LINEAR DNA REPLICATION |
4 | 0.0000118100 | EPIDEMIC KERATOCONJUNCTIVITIS//OPHTHALMOLHOWE//ADENOVIRUS TYPE 8 |
5 | 0.0000081471 | GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS |
6 | 0.0000061926 | FOWL ADENOVIRUS//INCLUSION BODY HEPATITIS//HYDROPERICARDIUM SYNDROME |
7 | 0.0000060395 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE |
8 | 0.0000046284 | HRV2//DISOXARIL//VIENNA BIO MED BIOCHEM |
9 | 0.0000040688 | HEMAGGLUTINATING VIRUS OF JAPAN//GAX//HVJ LIPOSOME |
10 | 0.0000039181 | PHOTOCHEMICAL INTERNALIZATION//PHOTOCHEMICAL INTERNALISATION//CANC STEM CELL INNOVAT SFI CAST |